Nitroglycerin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nitroglycerin

Property Description
Active ingredient Nitroglycerin (Glyceryl trinitrate)
Forms Sublingual tablet, translingual spray, transdermal patch, ointment, IV solution
Pharmacological class Organic nitrate, Vasodilator
Common use Anti-ischemic agent
Origin Synthetic, small molecule

What is Nitroglycerin (Glyceryl Trinitrate) and What Kind of Drug Is It?

Nitroglycerin, known by its international nonproprietary name (INN) as Glyceryl trinitrate (GTN), is a synthetic, small-molecule drug primarily classified as a vasodilator and an antianginal agent. It belongs specifically to the organic nitrate pharmacological class.

Its classification as an organic nitrate is fundamental to its mechanism. This molecule is converted in the body to nitric oxide, which is a potent vasodilator. This substance is produced as a single active ingredient for use in its final preparations, and it has an established role as a primary anti-ischemic agent.


How is Nitroglycerin Made and What Forms Does it Take?

Nitroglycerin is manufactured as a single-ingredient product, combined with various inert carrier bases depending on the delivery method. The medicine is supplied in diverse dosage forms for varying needs, including sublingual tablets, translingual sprays, transdermal patches, topical ointments, and specialized intravenous solutions.

These multiple pharmaceutical preparations facilitate different routes of administration, allowing the medicine to be delivered for rapid relief or slowly absorbed over time for sustained effect. The transdermal patches are designed to ensure continuous release of the active substance through the skin for long-term action. This variability of form is a key distinguishing factor of Nitroglycerin among cardiovascular drugs.


What is the General Purpose of This Organic Nitrate?

The general purpose of this organic nitrate is to relieve discomfort or pressure associated with inadequate oxygen supply to the heart muscle by reducing the heart’s workload. It achieves this fundamental anti-ischemic agent role because its action causes widespread relaxation and venodilation (vein widening).

This primary action significantly lessens the amount of blood returning to the heart, a state known as reduction of preload. By reducing this volume, the heart requires less energy and oxygen to pump effectively, which directly serves the overall general benefit of improving blood flow and decreasing strain on the cardiovascular system.

Regulatory References

  1. U.S. National Library of Medicine
  2. The European Medicines Agency (EMA) highlights that the transdermal patches ensure continuous release of the active substance through the skin [for long-term action].

What side effects are possible with Nitroglycerin?

Possible Side Effects and Safety Information

This information describes the possible side effects and safety restrictions for nitroglycerin, as documented in official government regulatory sources.

Documented Adverse Reactions

Adverse reactions are classified based on their frequency of occurrence in clinical data:

Frequency Examples of Documented Side Effects
Very Common (occurs in 1 in 10 or more people) Headache
Common (occurs in 1 in 100 to less than 1 in 10 people) Dizziness, Hypotension (low blood pressure), Tachycardia (increased heart rate), Flushing
Frequency Not Known (cannot be estimated from available data) Exfoliative Dermatitis (severe skin inflammation)

Serious Safety Considerations

The most clinically significant adverse reactions that have been documented are Severe Hypotension (profoundly low blood pressure) and Syncope (fainting). These events are related to the drug's powerful vasodilating action.

Safety Restrictions and Limitations

Nitroglycerin is contraindicated and must not be used in the presence of certain medical conditions, including:

  • Use with PDE-5 inhibitors (e.g., sildenafil, vardenafil) or soluble guanylate cyclase stimulators (e.g., riociguat) due to the risk of severe, life-threatening hypotension and circulatory collapse.
  • Severe anemia.
  • Increased intracranial pressure or cerebral hemorrhage.
  • Circulatory collapse or shock.
  • Severe hypotension or uncorrected severe hypovolemia.
  • Certain severe heart conditions, such as hypertrophic obstructive cardiomyopathy, and aortic or mitral valve stenosis.

Exposure-Related Safety Patterns

Official documents note the risk of nitrate tolerance (a diminished effect of the drug) and physical dependence occurring after prolonged, high-level continuous exposure, such as has been observed in industrial settings.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Nitroglycerin (Glyceryl Trinitrate) is primarily marked by an extreme exaggeration of its intended vasodilatory effects, leading to severe hemodynamic instability. Documented manifestations listed in regulatory information include profound hypotension, syncope, persistent throbbing headache, vertigo, and generalized diaphoresis (sweating).

Severe Outcomes and Emergency Actions

More severe outcomes listed in official documents include circulatory collapse and the life-threatening condition of methemoglobinemia, which impairs the blood's ability to carry oxygen. The risk of methemoglobinemia is noted to be increased in patients with severe anemia.

Immediate medical attention is required if acute chest pain persists after a total of three doses (sublingual, spray, or tablet) administered within a 15-minute period. Furthermore, emergency services must be called immediately if severe central nervous system involvement occurs, such as collapse, seizures, or loss of consciousness.

Treatment focuses on symptomatic and supportive measures, with specific procedures like elevation of the extremities and fluid administration for hypotension. While no specific antidote is known for a general overdose, Methylene blue is specified for the treatment of clinically significant methemoglobinemia.

Therapeutic Uses of Nitroglycerin

What Nitroglycerin Treats: Main Uses and Benefits

This section focuses strictly on the symptomatic and therapeutic benefits provided by nitroglycerin, a medication commonly used to help manage symptoms associated with heart conditions. It is used to relieve chest pain in people who have coronary artery disease and to prevent angina episodes.

The medication is relevant for easing certain distressing symptoms associated with coronary artery disease and other conditions involving acute heart strain, including crushing chest pain (angina) and related discomfort. It is used in situations involving symptomatic discomfort and is commonly applied in clinical settings that involve acute or unstable symptom patterns.

Common Therapeutic Applications

Nitroglycerin supports the management of acute episodes of chest pain, contributes to the prevention of predictable symptoms, and assists with acute cardiac strain.

  • Support for Acute Chest Pain (Angina): This medication is commonly used for symptomatic relief of severe crushing or squeezing chest discomfort when symptoms appear suddenly or fluctuate. It provides supportive relief and supports patients during episodes of heightened discomfort.
  • Management of Predictable Symptoms: It is applied to manage predictable symptoms by being used before activities commonly known to cause chest pain. This use contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability.
  • Supportive Benefit in Acute Cardiac Strain: It provides supportive therapeutic benefit in contexts marked by increased discomfort or tension, such as acute heart strain, and is used for managing manifestations, helping to provide supportive relief when symptoms interfere with routine activities.

Quick Fact: Relief for Angina Symptoms

Regulatory References

  1. Nitroglycerin Sublingual: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Population Eligibility

The eligibility for using Nitroglycerin is defined by strict regulatory criteria, outlining populations who may use the medicine and those who are prohibited. Use is primarily established for adult patients. While generally permitted in older adults, caution is advised due to the higher likelihood of age-related organ function decline. The medicine is not established and therefore not recommended for the pediatric population.

Absolute Contraindications

Nitroglycerin is contraindicated and must not be used by specific groups. This includes patients with a known hypersensitivity to nitrates or those concurrently taking Phosphodiesterase Type 5 (PDE5) inhibitors. Absolute prohibitions also apply to patients with marked anemia, increased intracranial pressure (ICP), or severe cardiac conditions like Hypertrophic Obstructive Cardiomyopathy (HOCM).

Conditional Use and Restrictions

Use is restricted in populations with impaired organ function. For individuals with severe hepatic impairment or severe renal impairment, use requires special regulatory consideration. In pregnancy, use is advised only if clearly needed, and it is unknown if the drug is excreted during lactation.

What should I know about interactions with other medicines?

The interaction profile for Nitroglycerin (Glyceryl trinitrate) is defined by its potential for severe pharmacodynamic and pharmacokinetic interactions as documented in regulatory labeling.


Formal Contraindications and Restrictions

Co-administration with Phosphodiesterase-5 (PDE-5) Inhibitors (e.g., sildenafil, tadalafil) and Soluble Guanylate Cyclase (sGC) Stimulators (e.g., riociguat) is contraindicated. This mandatory restriction is due to the risk of potentiating hypotensive effects, which can lead to severe hypotension or myocardial ischemia. Regulatory documents also state that use of these agents within a few days of one another cannot be recommended. Additionally, use with Ergotamine and related drugs must be avoided.


Documented Pharmacodynamic Effects

The vasodilatory effects of nitroglycerin are additive to the effects observed with alcohol, which may result in hypotension. Other drug classes that require monitoring for additive hypotensive effects include Antihypertensive Drugs, Beta-adrenergic Blockers, Calcium Channel Blockers, and Phenothiazines.


Exposure-Altering Interactions

Regulatory information describes interactions that change drug levels. High-dose Aspirin co-administration is documented to increase the maximum concentrations and overall exposure (AUC) of nitroglycerin. Conversely, nitroglycerin may reduce the effect of other drugs: Intravenous Heparin's anticoagulant effect may be decreased, and Alteplase's thrombolytic effect may be reduced due to lower plasma levels of Alteplase. The need to avoid Ergotamine use is due to nitroglycerin decreasing the first-pass metabolism of ergotamines, increasing their bioavailability.

Mechanism of Action

How Nitroglycerin Works

The drug's action is defined by a biochemical cascade that modulates vascular tone. The mechanism is entirely dependent on enzyme-mediated transformation and subsequent activation of a key messenger system.


Enzyme-Driven Bioactivation and the NO Signaling Pathway

Nitroglycerin acts as an inactive prodrug that requires the enzyme Mitochondrial Aldehyde Dehydrogenase ( mtALDH) for conversion into Nitric Oxide ( NO). This NO molecule then initiates the central signaling process by binding to and activating the enzyme Soluble Guanylate Cyclase ( sGC) . This engagement begins the molecular cascade that results in the relaxation of vascular smooth muscle.


Modulation of Vascular Tone via the cGMP Cascade

The activation of sGC leads to a significant increase in the second messenger cGMP (cyclic Guanosine Monophosphate), which triggers a phosphorylation cascade resulting in the relaxation of vascular smooth muscle cells. This action, primarily in the venous system, increases the capacity of blood vessels, leading to a marked reduction in the volume of blood returning to the heart (cardiac preload). This physiological adjustment reduces the volume and pressure load placed on the cardiac muscle.

Dosage and Administration Information

How to Use Nitroglycerin

Nitroglycerin is utilized in clinical practice through multiple routes, and its administration pattern is governed by its dosage form to address either acute or long-term needs. Methods include sublingual (SL) tablets, translingual sprays, oral extended-release capsules, transdermal patches, topical ointment, and intravenous (IV) infusion.


Administration and Dosage Principles

Usage Context Official Dosing and Frequency Principle
Acute Relief (SL/Spray) A single dose (0.3 mg to 0.6 mg) may be repeated every 5 minutes, but administration should not exceed 3 doses within a 15-minute period.
Maintenance (Patch/Oral) Long-acting forms require a daily nitrate-free interval, typically lasting 10 to 12 hours, to avoid the development of tolerance.
Prophylaxis (SL/Spray) May be taken 5 to 10 minutes prior to an activity known to cause symptoms.
IV Infusion Initial continuous infusion rate is typically 5 mcg/minute, which is then adjusted in increments every 3 to 5 minutes based on the specific clinical requirement.

Procedural Conditions and High-Level Rules

For acute mucosal delivery, the dose is administered while the patient is at rest, preferably in a sitting position. Sublingual tablets must be allowed to dissolve under the tongue without chewing or swallowing. Intravenous administration requires the concentrate to be diluted in the appropriate solution and infused only through a controlled-infusion device and non-PVC tubing to ensure precise delivery. In the elderly population, dosing is generally initiated at the lower end of the adult range. Furthermore, clinical practice involves avoiding the abrupt discontinuation of high-dose or long-term therapy.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nitroglycerin

Evidence for Rapid Symptom Relief in Acute Chest Pain (Angina)

Research has widely examined the effects of quick-acting forms of Nitroglycerin, such as sublingual tablets and sprays, in patients during episodes of chest pain. These studies, including older and more recent Randomized Controlled Trials (RCTs), were conducted during periods of heightened symptom activity. The primary outcomes monitored are outcomes related to physical discomfort, specifically the time until changes in chest pain symptoms were reported.

Studies were evaluated in the context of acute symptoms, and research highlights changes measured during the short-term study period. The evidence in this acute context is generally considered to have a High level of characterization, meaning the patterns observed across studies are consistent. However, these studies provide insight into short-term changes only, and the findings describe group patterns, not personal outcomes.

Research on Long-Term Management of Predictable Symptoms (Chronic Stable Angina)

Research for long-term use, involving formulations like patches or extended-release tablets, was evaluated in trials lasting several weeks or months. These studies typically involved adults with chronic stable angina. The outcomes monitored in these trials were outcomes reflecting daily functioning or activity level, such as the total time spent exercising and the weekly count of episodes of physical discomfort.

Studies explored intermittent dosing schedules, and research highlights changes measured during the study period related to the patients' exercise tolerance. Findings from certain trials data show patterns related to a loss of the measured effect over time, a pattern known as "nitrate tolerance," which was observed in some studies with continuous treatment. Evidence is limited by the persistent challenge of nitrate tolerance. Follow-up durations were limited for many of these long-term studies, and there is limited information for long-term outcomes on major cardiovascular events.

Studies in Acute Heart Strain and Cardiac Events

The research examining the use of Nitroglycerin in emergency or critical care settings, such as for acute coronary syndromes or acute heart failure, primarily involves older RCTs and retrospective observational studies using intravenous (IV) solutions. These studies monitored physiological strain or stress, including measures related to blood pressure and outcomes related to physical discomfort. While some older trials described findings indicate patterns related to specific early treatment scenarios, these trials often pre-date major advancements in current emergency heart care. The findings were mixed when the patient population was analyzed as a whole, and the evidence quality varies across studies.

Key Studies & References

  1. Public Assessment Report Scientific discussion Nitroglycerin Abcur (glyceryl trinitrate) - EMA/National Procedure (IV use)
  2. Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris (RCT on tolerance/exercise capacity)

Frequently Asked Questions (FAQ)

Common questions about Nitroglycerin (FAQ)

Q: How quickly should I expect Nitroglycerin to start working?

According to official patient information for the acute forms, a person should generally expect to feel relief or an improvement in symptoms within about 5 minutes after the first dose. This quick onset is related to the drug's rapid absorption into the body via the sublingual or translingual route.


Q: How long does the effect of a dose of Nitroglycerin typically last?

The vasodilatory effect of the quick-acting forms, such as the sublingual tablet or translingual spray, is generally noted in official prescribing information to last for approximately 30 minutes to 60 minutes.


Q: Is it normal to feel a slight tingling or burning sensation with the sublingual tablet?

The specific sensation of tingling or burning under the tongue is not typically listed in the documented common or very common adverse reaction profiles in official regulatory documents. Commonly documented adverse reactions include headache, dizziness, or flushing, according to official regulatory profiles.


Q: What happens if Nitroglycerin is exposed to air or heat?

Official storage requirements emphasize keeping the medicine protected from moisture, light, air, and away from heat. Exposure to these elements may be associated with the medication losing its potency (its effectiveness) over time. This is why strict storage in the original container is necessary.


Q: Does using Nitroglycerin regularly make it less effective over time (tolerance)?

Yes, regulatory documents note the risk of developing nitrate tolerance, which means the drug's effect may diminish with continuous use. To minimize this, official guidance for long-acting forms advises including a daily nitrate-free interval (a time when the drug is not taken).


Q: What should I do if the Nitroglycerin doesn't seem to work after the first dose?

Official instructions state that if the first dose does not bring relief, the dose may be repeated every 5 minutes. However, administration should generally not exceed three doses within a 15-minute period. If discomfort persists after the maximum number of doses described in the patient instructions, seeking prompt medical attention is generally advised.


Q: Are there different forms of Nitroglycerin, like patches, tablets, and sprays?

Yes. According to official labeling, Nitroglycerin is supplied in various dosage forms to serve different purposes. These forms include sublingual tablets, translingual sprays, transdermal patches, topical ointments, and specialized intravenous solutions.


Q: Does Nitroglycerin only treat symptoms, or does it help prevent heart issues?

Regulatory indications show that the drug is used for both the acute relief of existing discomfort and for the prophylactic (preventive) management of symptoms associated with chronic conditions. It works by reducing the heart's workload.


Q: What are the general differences in how the patch versus the spray works?

The translingual spray or sublingual tablet is a short-acting form intended for acute, rapid relief of sudden symptoms. In contrast, the transdermal patch is a long-acting form intended for maintenance and the sustained prevention of symptoms over a longer period of time.


Q: Is it okay if I accidentally swallow a little bit of the sublingual tablet?

Official instructions advise that the sublingual tablet must dissolve under the tongue and should not be chewed or swallowed whole for it to work correctly. If the dose is swallowed, it may not achieve the intended therapeutic effect because the drug relies on sublingual absorption.


Q: Is it true that the effectiveness of the sublingual tablet is affected by a dry mouth?

Patient instructions for the sublingual tablet often note that the presence of moisture or saliva around the tablet will help it to dissolve more quickly. Therefore, a very dry mouth may slow down the necessary dissolution process.


Q: Is the severity of the headache related to the drug's effectiveness?

Yes, in certain official documents, the headache, which is a very common side effect, is sometimes described as a marker of the drug's activity (its vasodilating effect). Official product information cautions that avoiding the use of the drug to prevent headache may be associated with a loss of the drug’s necessary effect.


Q: Is Nitroglycerin the same as an aspirin?

No, official drug classifications indicate they are different. Nitroglycerin is classified as an organic nitrate and a vasodilator, meaning it opens blood vessels. Aspirin is classified as a salicylate and an antiplatelet agent, meaning it affects blood clotting.


Q: Can Nitroglycerin cause my blood pressure to drop too low?

Yes. Because the drug is a powerful vasodilator (opens blood vessels), official safety information documents Hypotension (low blood pressure) as a common side effect and Severe Hypotension as a serious safety consideration. This risk is documented to be increased when the drug is used with certain other medications.


Q: Is it true that alcohol should be avoided completely when using Nitroglycerin?

Regulatory documents indicate that the vasodilatory effects of nitroglycerin are additive to the effects of alcohol. This combination may lead to an increased risk of significant hypotension (low blood pressure), dizziness, or fainting.


Q: Why is it important to sit down when using the sublingual spray or tablets?

The instruction to be at rest, preferably sitting, is related to the drug's rapid vasodilatory action, which may carry a risk of dizziness or fainting spells (syncope) from a rapid drop in blood pressure. This is intended to help prevent falls or injury.


Q: Are there any foods or drinks that can affect how Nitroglycerin works?

Regulatory patient information often advises patients not to eat, drink, smoke, or chew tobacco while a sublingual tablet is dissolving. This is to prevent interference with the drug's intended absorption through the lining of the mouth.


Q: What are the signs of a serious or allergic reaction to Nitroglycerin?

While rare, serious reactions are documented in safety information. These include a profound drop in blood pressure that can lead to circulatory collapse or shock. Serious skin inflammation, such as Exfoliative Dermatitis, is also listed as a potential, though uncommon, adverse reaction.


Q: What does research evidence generally indicate about the long-term use of Nitroglycerin?

Official summaries of clinical studies indicate patterns related to the development of nitrate tolerance during long-term continuous use. Research evidence also indicates that studies focusing on the impact on major cardiovascular outcomes have been characterized by limited follow-up durations.


Q: Are there any specific activities to avoid after taking Nitroglycerin?

Regulatory patient safety information advises caution regarding activities that require full mental alertness. Individuals should avoid driving or operating hazardous machinery until they know how the medication affects them, due to the potential for dizziness or fainting.


Q: Can children or teenagers ever be prescribed Nitroglycerin?

Regulatory documents state that the medicine is primarily established for use in adult patients. It is generally not established and therefore not recommended for the pediatric population (children and teenagers).


Q: Can people with high blood pressure (hypertension) use Nitroglycerin?

Yes, official documents indicate the drug is sometimes used in specific clinical settings to manage elevated blood pressure (hypertension). It is also commonly used alongside other antihypertensive drugs, though monitoring for additive hypotensive effects is required.


Q: What does the term 'anti-anginal' mean when discussing Nitroglycerin?

Nitroglycerin is classified as an anti-anginal agent. This term is used to describe a drug that treats angina pectoris, which is the discomfort or pressure associated with inadequate oxygen supply to the heart muscle.


Q: Is Nitroglycerin considered a first-line treatment for its primary use?

Authoritative clinical guidelines generally referenced in drug monographs indicate that sublingual (under-the-tongue) nitroglycerin is widely recommended as a first-line agent for the rapid relief of ongoing ischemic pain (symptoms related to reduced blood flow) in certain conditions.


Q: What kind of studies have been done on Nitroglycerin?

Research evidence summarized in regulatory documents includes studies such as Randomized Controlled Trials (RCTs) and retrospective observational studies. These studies have primarily examined the drug's effects on short-term symptom relief and the management of chronic conditions.


Q: Does Nitroglycerin have any known effects on kidney or liver function?

Regulatory documents advise that use is restricted in patients with severe hepatic (liver) impairment or severe renal (kidney) impairment and may require special consideration. However, one official document states no dosage adjustment is required in patients with renal failure.


Q: What is the general classification of Nitroglycerin based on official sources?

Based on official documents, Nitroglycerin is officially classified as an organic nitrate drug. Its therapeutic classification is that of a vasodilator (opens blood vessels) and an anti-anginal agent.


Q: Is Nitroglycerin a commonly abused or controlled substance?

No. Official documents from regulatory bodies, such as the U.S. Controlled Substances Act, show that Nitroglycerin is not currently classified as a controlled substance and has no documented pattern of common abuse.


Q: Can I keep Nitroglycerin in my wallet or pocket for easy access?

Official storage requirements state the medicine must be kept in its original container to protect it from moisture and light. Furthermore, it should be stored away from heat to maintain its effectiveness, which may be difficult to ensure in a wallet or pocket.

How should Nitroglycerin be stored and disposed of?

How to Store and Dispose of Nitroglycerin?

The storage and disposal of nitroglycerin must adhere to official regulatory labeling to maintain stability and effectiveness.


Official Storage Requirements

Nitroglycerin products must generally be stored at controlled room temperature (15 C to 30 C or 59 F to 86 F), protected from moisture and light, and kept away from heat and open flame. Sublingual tablets must remain in their original, tightly closed glass container. All forms must be stored out of the reach of children and pets.


Official Disposal Instructions

For disposal, used and unused transdermal patches must be folded in half with the sticky sides together. Unused tablets and capsules should be prepared for household trash by mixing them with an undesirable substance (like dirt or coffee grounds) in a sealed bag, preventing accidental ingestion.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nitroglycerin found in:

A-Z Index: